London ? Greg Rusedski was cleared by an anti-doping panel Wednesday, the eighth player to fail a drug test yet be exonerated because he took supplements supplied by ATP trainers.

The 1997 U.S. Open runner-up tested positive for the steroid nandrolone at a tournament in Indianapolis in July, and he faced a two-year ban if found guilty.

Rusedski appeared Feb. 9 in Montreal before an independent anti-doping panel, which ruled “unanimously and unequivocally that Mr. Rusedski was not guilty of a doping offense.”

“This is an enormous relief to me,” the British player said. “To be allowed to carry on playing competitive tennis and to clear my name has been my priority throughout, and now I am looking forward to resuming my career.”

He denied using the steroid and maintained his test result was similar to those of seven other players who tested positive for nandrolone but escaped suspension.

“This is a case where a governing body has itself given substances to players — in this case electrolytes — which have tested positive,” said Rusedski’s lawyer, Mark Gay. “Where a governing body itself has put these things into circulation, it’s hardly the player’s fault if he tested positive.”

But the World Anti-Doping Agency called the panel’s ruling “greatly disturbing.” It said there was no conclusive evidence that the supplements provided by ATP trainers were the source of the eight positive tests.

WADA will issue a report on its investigation into the seven earlier nandrolone cases in tennis. Rusedski tested positive two months after the ATP instructed its staff to stop issuing the supplements.

The ATP announced this month it is forming a panel to educate players about nutritional supplements. The panel’s first meeting is March 23 in Miami.